SALEKI-GERHARDT AZITA — SEC Form 4 filings
SEC reporting owner CIK 1563545. 12 Form 4 filings on record with FilingPulse; latest filed 2026-05-08.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-02-20 to 2026-05-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 95,240 shares, $17,591,103 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 26.
- Largest priced transaction: sale of 52,870 shares @ $173.71 ($9,184,048) in AbbVie Inc., filed 2024-02-23.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| AbbVie Inc. (ABBV) | EVP, CHIEF OPERATIONS OFFICER | 9 | — | 2 legs · 95,240 sh · $17,591,103 | 23 |
| ENTEGRIS INC (ENTG) | Director | 3 | — | — | 3 |
Form 4 filings — SALEKI-GERHARDT AZITA
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-08 | 4 | ENTEGRIS INC (ENTG) | Grant/award (A): 1,412 @ $0 | EDGAR |
| 2026-03-03 | 4 | AbbVie Inc. (ABBV) | Tax withholding (F): 16,309 @ $232.08 | EDGAR |
| 2026-02-20 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 17,041 @ $0 · Grant/award (A): 6,058 @ $0 · Grant/award (A): 7,074 @ $0 · Grant/award (A): 6,638 @ $0 · Grant/award (A): 20,312 (derivative) @ $0 | EDGAR |
| 2025-08-14 | 4 | AbbVie Inc. (ABBV) | Option exercise (M): 42,370 @ $54.86 · Sale (S): 42,370 @ $198.42 · Option exercise (M): 42,370 (derivative) @ $54.86 | EDGAR |
| 2025-04-25 | 4 | ENTEGRIS INC (ENTG) | Grant/award (A): 2,897 @ $0 | EDGAR |
| 2025-03-04 | 4 | AbbVie Inc. (ABBV) | Tax withholding (F): 17,056 @ $205.02 | EDGAR |
| 2025-02-18 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 17,986 @ $0 · Grant/award (A): 7,378 @ $0 · Grant/award (A): 6,060 @ $0 · Grant/award (A): 7,074 @ $0 · Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-09-30 | 4 | AbbVie Inc. (ABBV) | Gift (G): 25,630 @ $0 | EDGAR |
| 2024-04-25 | 4 | ENTEGRIS INC (ENTG) | Grant/award (A): 1,643 @ $0 | EDGAR |
| 2024-03-01 | 4 | AbbVie Inc. (ABBV) | Tax withholding (F): 23,966 @ $178.99 | EDGAR |
| 2024-02-23 | 4 | AbbVie Inc. (ABBV) | Option exercise (M): 52,870 @ $58.88 · Sale (S): 52,870 @ $173.71 · Option exercise (M): 52,870 (derivative) @ $58.88 | EDGAR |
| 2024-02-20 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 32,097 @ $0 · Grant/award (A): 8,558 @ $0 · Grant/award (A): 7,380 @ $0 · Grant/award (A): 6,060 @ $0 · Grant/award (A): 29,313 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1563545 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →